{
    "Trade/Device Name(s)": [
        "BD Phoenix\u2122M Automated Microbiology System - Vancomycin (0.5-32 \u03bcg/mL)",
        "BD Phoenix\u2122 Automated Microbiology System- Vancomycin (0.5-32 \u03bcg/mL) - Gram Positive ID/AST or AST only Phoenix Panels and update to the BD Phoenix Software through Version 6.01"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K131331",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "May 3, 2013",
    "Summary Letter Received Date": "May 13, 2013",
    "Submission Date": "May 3, 2013",
    "Regulation Number(s)": [
        "21CFR866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of gram positive bacteria",
        "Gram-negative aerobic and facultative anaerobic bacteria",
        "Enterobacteriaceae",
        "NonEnterobacteriaceae"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth-based microdilution",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing (AST)",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "Automated system",
        "Panel",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System modification for Vancomycin MIC testing with updated software through Version 6.01",
    "Indications for Use Summary": "Quantitative determination of antimicrobial susceptibility by MIC for most gram-negative aerobic and facultative anaerobic bacteria (Enterobacteriaceae, NonEnterobacteriaceae) and gram-positive bacteria (Staphylococcus, Enterococcus, Streptococcus) from pure culture, specifically for Vancomycin algorithm update and software upgrade.",
    "fda_folder": "Microbiology"
}